159 related articles for article (PubMed ID: 30852628)
21. Budesonide enhances agonist-induced bronchodilation in human small airways by increasing cAMP production in airway smooth muscle.
Koziol-White C; Johnstone TB; Corpuz ML; Cao G; Orfanos S; Parikh V; Deeney B; Tliba O; Ostrom RS; Dainty I; Panettieri RA
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L345-L355. PubMed ID: 31747297
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells.
Che W; Manetsch M; Quante T; Rahman MM; Patel BS; Ge Q; Ammit AJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1658-65. PubMed ID: 22743041
[TBL] [Abstract][Full Text] [Related]
23. Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages.
Jalonen U; Paukkeri EL; Moilanen E
J Pharmacol Exp Ther; 2008 Aug; 326(2):514-22. PubMed ID: 18469159
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of histamine-evoked Ca
Dale P; Head V; Dowling MR; Taylor CW
Cell Calcium; 2018 May; 71():53-64. PubMed ID: 29604964
[TBL] [Abstract][Full Text] [Related]
25. A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype‑3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells.
Liu YH; Wu SZ; Wang G; Huang NW; Liu CT
Mol Med Rep; 2015 Jun; 11(6):4121-8. PubMed ID: 25672589
[TBL] [Abstract][Full Text] [Related]
26. β2-adrenergic receptor agonists modulate human airway smooth muscle cell migration via vasodilator-stimulated phosphoprotein.
Goncharova EA; Goncharov DA; Zhao H; Penn RB; Krymskaya VP; Panettieri RA
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):48-54. PubMed ID: 22210825
[TBL] [Abstract][Full Text] [Related]
27. Prolonged heterologous beta2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 induction.
Hu A; Nino G; Grunstein JS; Fatma S; Grunstein MM
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1055-67. PubMed ID: 18359889
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
29. MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells.
Manetsch M; Che W; Seidel P; Chen Y; Ammit AJ
Cell Signal; 2012 Apr; 24(4):907-13. PubMed ID: 22200679
[TBL] [Abstract][Full Text] [Related]
30. Beta-2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1.
Salomon JJ; Hagos Y; Petzke S; Kühne A; Gausterer JC; Hosoya K; Ehrhardt C
Mol Pharm; 2015 Aug; 12(8):2633-41. PubMed ID: 25751092
[TBL] [Abstract][Full Text] [Related]
31. Agonist-specific desensitization of PGE
Nunez FJ; Schulte NA; Fogel DM; Michalski J; Rennard SI; Penn RB; Toews ML; Ostrom RS
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):843-856. PubMed ID: 31884570
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure.
Nino G; Hu A; Grunstein JS; Grunstein MM
J Allergy Clin Immunol; 2010 May; 125(5):1020-7. PubMed ID: 20392484
[TBL] [Abstract][Full Text] [Related]
33. Compartmentalized cAMP responses to prostaglandin EP
Agarwal SR; Miyashiro K; Latt H; Ostrom RS; Harvey RD
Br J Pharmacol; 2017 Aug; 174(16):2784-2796. PubMed ID: 28603838
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C.
Fiebich BL; Schleicher S; Spleiss O; Czygan M; Hüll M
J Neurochem; 2001 Dec; 79(5):950-8. PubMed ID: 11739606
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
36. Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E
Tang T; Scambler TE; Smallie T; Cunliffe HE; Ross EA; Rosner DR; O'Neil JD; Clark AR
Sci Rep; 2017 Jun; 7(1):4350. PubMed ID: 28659609
[TBL] [Abstract][Full Text] [Related]
37. β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D.
Trian T; Burgess JK; Niimi K; Moir LM; Ge Q; Berger P; Liggett SB; Black JL; Oliver BG
PLoS One; 2011; 6(5):e20000. PubMed ID: 21611147
[TBL] [Abstract][Full Text] [Related]
38. Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.
Billington CK; Hall IP
Respir Res; 2011 Jul; 12(1):89. PubMed ID: 21722392
[TBL] [Abstract][Full Text] [Related]
39. ASM-024, a piperazinium compound, promotes the in vitro relaxation of β2-adrenoreceptor desensitized tracheas.
Israël-Assayag E; Beaulieu MJ; Cormier Y
PLoS One; 2015; 10(3):e0120095. PubMed ID: 25799096
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lysyl oxidase by prostaglandin E2 via EP2/EP4 receptors in human amnion fibroblasts: Implications for parturition.
Liu C; Zhu P; Wang W; Li W; Shu Q; Chen ZJ; Myatt L; Sun K
Mol Cell Endocrinol; 2016 Mar; 424():118-27. PubMed ID: 26826430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
